Beijing Wantai Biological Pharmacy Enterprise (SHA:603392) swung to an attributable loss of 29.4 million yuan in the third quarter from a profit of 6.2 million yuan in the year-ago period, according to a Thursday filing with the Shanghai bourse.
The medical products manufacturer swung to a loss per share of 0.02 yuan from earnings per share of 0.005 yuan in the prior-year period.
Operating income grew 13% year over year to 654.8 million yuan from 582.1 million yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments